150
Participants
Start Date
July 31, 1999
Study Completion Date
October 31, 2000
Hydroxyurea
Abacavir sulfate
Efavirenz
Didanosine
Beth Israel Med Ctr, New York
Saint Luke's - Roosevelt Hosp Ctr, New York
Anderson Clinical Research Inc, Reading
Hampton Roads Med Specialists, Hampton
Univ of North Carolina / Infectious Disease Division, Chapel Hill
Univ of NC Infectious Diseases, Wilmington
Burnside Clinic, Columbia
Gary Richmond MD, Fort Lauderdale
Saint Josephs Comprehensive Research Institute, Tampa
Univ of Kentucky Med Ctr, Lexington
Northstar Med Clinic, Chicago
Univ of Texas / Thomas Street Clinic, Houston
Univ of Texas Med Branch, Galveston
Altamed Medical Health Services, Los Angeles
Pacific Oaks Research, Beverly Hills
St Lukes Medical Group, San Diego
Pacific Horizons Med Group, San Francisco
East Bay AIDS Ctr, Berkeley
Univ of Miami School of Medicine, Miami
Univ of Nebraska Medical Ctr, Omaha
Boston Med Ctr / Evans - 556, Boston
CRI of New England, Brookline
Miriam Hosp, Providence
Lead Sponsor
Glaxo Wellcome
INDUSTRY